证券之星消息，2025年5月8日中电港（001287）发布公告称公司于2025年5月8日召开业绩说明会。 具体内容如下： 问：中电港2024年的增长主要来自于存储和处理器，请产品主要应用在哪些领域？ 答：公司2024年授权分销业务中，存储器业务收入206.85亿元，同比增长134.32%；处理器业务收入 149.72亿元，同比增长33.60%。主要是消费终端及I服务器相关客户需求增长，带动了存储器、处理器 的出货量增加。 问：中电港2024年收入增速高于利润增速的主要原因是什么，后续有哪些升利润升计划？ 答：2024年，公司积极推进稳健运营、精细管控，抢抓市场发展机遇，实现营业收入486.39亿元人民 币，同比提升40.97%。但受到电子信息产业链各环节的毛利率持续承压，以及毛利率相对较低的存储 器市场需求较高等因素影响，导致公司低毛利业务的收入占比较高，全年实现归属于上市公司股东的净 利润2.37亿元人民币，同比增长0.18%。 2025年，公司将继续以"合规控险,降本增效,价值引领"为经营总方针，全力打造电子元器件科技型综合 服务平台，以分销服务为根基，加快推动设计链服务、供应链综合服务和产业数据服务等高 ...

证券代码：001287 证券简称：中电港 深圳中电港技术股份有限公司 投资者关系活动记录表 编号：2025-01 | | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | 投资者关系活动类别 | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及人员姓名 | 线上参与公司2024年度网上业绩说明会的全体投资者 | | 时间 | 2025年5月8日 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 董事长 朱颖涛 | | | 董事、总经理 刘迅 | | 上市公司接待人员姓名 | 独立董事 蔡元庆 | | | 财务总监 田茂明 | | | 董事会秘书 刘同刚 | | | 保荐代表人 王申晨 | | | 1、中电港2024年的增长主要来自于存储和处理器，请问产品主 | | | 要应用在哪些领域？ | | | 公司2024年授权分销业务中，存储器业务收入206.85亿元，同比 | | 投资者关系活动 | 增长134.32%；处理器业务 ...

Group 1: Company Growth Drivers - The main drivers for future profit growth include the modernization of traditional industrial technology and the ongoing demand for industrial automation instruments due to economic transformation in China [2][3] - The rapid development of the natural gas industry and urban infrastructure projects provide significant opportunities for gas detection and alarm devices [3] Group 2: Competitive Strategy - The company focuses on continuous R&D investment and innovation to maintain a competitive edge in the industrial automation control sector [3] - A dual approach of "independent innovation + international cooperation" is employed to enhance core technology and promote domestic alternatives for high-end instruments [3] Group 3: Financial Performance and Challenges - The company has reported losses for three consecutive years, with the previous year marking its first loss [4] - A new management model based on "platform organization + ecological operation" aims to improve performance and enhance core competitiveness [4] Group 4: Asset Management - The company has accumulated goodwill of 238.86 million yuan, with a remaining goodwill of 37.99 million yuan after impairment [4] - The company is currently advancing the approval process for a project funded by convertible bonds for building construction [4]

Group 1: Company Overview - The main products and services include dynamic pressure oil film sliding bearings, wind power sliding bearings, high-speed permanent magnet motor products, and industrial transmission services, focusing on energy generation, industrial drive, petrochemicals, and shipping sectors [2] - In 2024, the company achieved operating revenue of CNY 518 million and a net profit attributable to shareholders of CNY 115 million [2] Group 2: Financial Performance - In Q1 2025, the company reported operating revenue of CNY 121 million and a net profit attributable to shareholders of CNY 27.81 million [2] - For 2024, revenue by industry shows: - Industrial drive: CNY 298 million (57.64%) - Energy generation: CNY 121 million (23.31%) - Petrochemicals: CNY 44 million (8.41%) - Shipping: CNY 26 million (4.93%) - Other: CNY 30 million (5.70%) [3] Group 3: International Business - The company’s international business, including direct exports and domestic factory support, has been growing rapidly, with direct export revenue reaching CNY 80.68 million in 2024, a year-on-year increase of 27.87% [4] Group 4: Nuclear Power Sector - The company has developed high-reliability sliding bearing solutions for the nuclear power sector, with a significant increase in orders for nuclear power bearings [5] Group 5: Dividend Policy - The company actively implements a cash dividend policy, prioritizing cash dividends over stock dividends, and may consider mid-term profit distributions under certain conditions [6] Group 6: Product Development - The company has established a research team for gas-lift bearings, focusing on a development model of "independent research + international cooperation + technology introduction" [7] Group 7: Capacity Utilization - The company has improved capacity utilization through optimization of production equipment, processes, and logistics, with plans for significant capacity increases as new projects come online [8]

Group 1: 弘亚数控 - In Q1 2025, domestic sales accounted for approximately two-thirds of total revenue, showing a slight year-on-year decline, while overseas sales experienced a certain degree of growth [1] - The increase in foreign exhibitors at the March exhibition indicates potential for new overseas customer orders, which may require a longer lead time [1] - The company maintains a cautiously optimistic outlook for the market this year, believing that continuous industry growth will provide development space [1] Group 2: 华大智造 - Revenue decline in Q1 2025 was primarily due to seasonal fluctuations and market uncertainties, with expectations for revenue from platform replacement orders in Q2 [2] - Increased competition has led to a decrease in average selling prices of core products, impacting gross margins; the company is implementing measures such as domestic material substitution to improve margins [2] - The company plans to continue cost reduction and efficiency improvement initiatives, with significant reductions in expense ratios expected [2] Group 3: 同兴科技 - The sodium-ion battery cathode materials utilize a poly-anion route, offering advantages such as low cost, low temperature, and high safety, mainly applied in large-scale energy storage and two-wheeled vehicles [3] - The third-generation NFPP has completed pilot-scale experiments, demonstrating high specific capacity and long cycle stability, and has been used in large-scale commercial energy storage projects [3] - The company is optimistic about its carbon capture business and has established a CCUS division to advance multiple projects and technological collaborations [3]

Group 1: 华大智造 (BGI Genomics) - Revenue decline in Q1 2025 attributed to seasonal fluctuations and market uncertainties, with expectations for revenue recovery in Q2 from platform replacement orders [1] - Increased competition leading to a decline in average selling prices of core products, impacting gross margins; the company is implementing measures such as domestic material substitution and optimizing revenue structure to enhance gross margins [1] - Anticipated revenue growth in Q4 2024, but still facing losses due to promotional discounts, increased new business contributions, and expense provisions [1] - The company is focusing on cost reduction and efficiency improvement, with significant reductions in expense ratios expected [1] - The impact of US tariffs on gross margins is noted, with low overseas procurement ratios and some reliance on imported components; domestic substitution efforts are ongoing [1] - Plans to stock up in advance to mitigate short-term impacts and establish overseas factories for reagent supply [1] - The company has received 750 intentions for switching from 3,000 existing Illumina instruments, offering high-performance alternatives [1] - AI technology is being leveraged to optimize enzymes for sequencing speed and quality, alongside developing energy-efficient transportation methods [1] - The overseas commercialization strategy is tailored to local markets, focusing on mature markets in Europe and the US, while also paying attention to Asia-Pacific and emerging markets [1] - Domestic advancements in NIPT upgrades, infectious disease testing, tumor early screening, rare disease detection, and innovation in the research field are ongoing [1] Group 2: 微芯生物 (Microchip Biotech) - Introduction of sodium siglitazone for the treatment of fatty liver or MASH, already approved for type 2 diabetes and included in medical insurance, showing multiple benefits such as improved insulin resistance and liver fat reduction [2] - Ongoing Phase III clinical trial for the combination of sidarubicin with sintilimab and bevacizumab for advanced colorectal cancer, with 200 out of 430 planned cases enrolled as of April 3, 2025 [2] - Several projects including CS23546, CS231295, and others are in Phase I and II clinical stages, with CS23546 having completed four dose escalation groups [2] - Business development (BD) is a key focus, with efforts to enrich multi-ethnic drug data for future BD initiatives [2] - The company is leveraging its subsidiary's advantages in large molecule drug development to explore new drug forms like DC, with relevant drugs having completed PCC development [2] Group 3: 南芯科技 (Nanchip Technology) - Anticipated 179% growth in automotive business in 2024, contributing over 3% to revenue, with continued rapid growth expected in 2025 across four key areas: body control, intelligent driving, smart cockpit, and onboard charging [3] - R&D expense ratio is 17.01%, expected to remain similar in 2025; acquisition of Shengsheng Micro will enhance business and supply chain capabilities [3] - Industrial applications include energy storage, drones, and battery systems, with multiple new products set to launch in 2024 and future expansions into IPower, industrial automation, and robotics [3] - The wired charging business maintains a leading position, with a trend towards integration and systematization, expecting significant breakthroughs in 2024 and even greater market achievements in 2025 [3] - The company is managing production capacity effectively in response to tight supply at some wafer and packaging factories, with stable pricing for wafer procurement and packaging testing [3] - Introduction of automotive-grade high-speed CN/CNFD transceiver product SC25042Q, with plans for more power and drive products in the future [3] - The company is pursuing a dual strategy to expand sales channels by targeting both large customers and distributors [3] - Following the acquisition of Shengsheng Micro, a transaction payment of 700 million was made in Q1, resulting in goodwill [3]

Core Viewpoint - The company has reported significant growth in its automotive business, driven by expansion in both domestic and international markets, while facing challenges in profitability due to increased costs and reduced orders in its aerospace segment [2][3]. Automotive Business - The growth drivers for the automotive business include expansion in exports, new customer development (notably with NIO, BYD, and others), product category expansion, industry concentration, and domestic substitution [2]. - The estimated value of fasteners for a mid-sized passenger vehicle is around 2,000 yuan, with the company's focus on small-sized fasteners valued at approximately 800 yuan per vehicle [4]. Financial Performance - In Q1 2025, the company reported a main revenue of 189 million yuan, a year-on-year increase of 38.36%, and a net profit attributable to shareholders of 15.99 million yuan, up 27.18% year-on-year [10]. - The company’s gross profit margin stands at 23.48%, with a debt ratio of 35.81% [10]. Aerospace Business - The company has made progress in its aerospace segment, particularly in the manufacturing of commercial rocket structural components, having completed production line construction and begun batch deliveries [6][7]. - The estimated value of structural components for a commercial rocket is around 15 million yuan, with potential increases to 25-30 million yuan following the completion of additional production lines [8]. Robotics Business - The humanoid robotics sector is identified as a key business direction, with initial small batch orders received from clients, although large-scale orders are not yet realized due to the industry not reaching a mass production stage [5]. R&D and Product Development - The company is leveraging its expertise in automotive fasteners to develop aerospace fastener products, with some already delivered to customers [10].

Group 1: Automotive Business Performance - The company's automotive parts revenue is driven by the expansion of exports and new domestic customer development, maintaining stable growth [2][3] - Key factors for growth include new customer acquisition (e.g., NIO, BYD), product category expansion, industry concentration increase, and domestic substitution [2][3] - The estimated value of fasteners for a mid-sized passenger vehicle is around 2,000 CNY, with the company's small-sized fasteners valued at approximately 800 CNY per vehicle [3] Group 2: Financial Performance and Challenges - The main reasons for revenue growth without profit increase include reduced orders in the aerospace business and rising sales and management expenses due to increased business scale [2][3] - The aerospace business has seen a decrease in orders, impacting current performance, while commercial space rocket structural components have not yet achieved large-scale delivery [2][3] Group 3: Robotics and Aerospace Business Development - The humanoid robot business is a significant direction for the company, with small batch orders received from clients like Zhiyuan Robotics, but large-scale orders are still pending [3] - The commercial aerospace sector is expanding, focusing on manufacturing rocket body structural components, with production lines completed in 2024 and initial deliveries made [3] - The estimated value of structural components in a mainstream commercial rocket is around 1.5 million CNY, with potential increases to 2.5-3 million CNY after the completion of the fuel tank production line [3] Group 4: R&D and Competitive Advantages - The company is actively developing aerospace fastener products, leveraging its extensive experience in automotive fasteners [3] - Competitive advantages in the aerospace sector include a specialized team with rich experience and the financial capability to invest in equipment and production line construction [3][4]

Group 1 - The semiconductor industry index (931865) experienced a decline of 1.15% as of May 7, 2025, with mixed performance among constituent stocks [3] - Jianghua Micro (603078) led the gains with an increase of 2.53%, while Huafeng Measurement Control (688200) saw the largest drop at 4.55% [3] - The semiconductor industry ETF (159582) decreased by 0.81%, with a latest price of 1.46 yuan and an active trading volume of 19.79 million yuan [3] Group 2 - Domestic AI model technology, represented by Deepseek, is driving demand for edge AI computing power, positively impacting the market for high-performance Ethernet switches, advanced storage products, GPUs, and edge computing chips [4] - The traditional consumer electronics sector has seen inventory levels normalize, with smartphones, PCs, and IoT benefiting from a recovery in market demand and supportive policies [4] - The semiconductor industry ETF has reached a new high in size at 160 million yuan [4] Group 3 - As of May 6, 2025, the semiconductor industry ETF has seen a net value increase of 40.80% over the past year, ranking 112 out of 2774 in equity funds [5] - The ETF has a management fee of 0.50% and a custody fee of 0.10%, which are among the lowest in comparable funds [5] - The tracking error for the ETF over the past year is 0.056%, indicating high tracking precision compared to similar funds [5] Group 4 - The top ten weighted stocks in the semiconductor industry index account for 76.35% of the index, with North Huachuang (002371) having the highest weight at 15.51% [6] - The performance of the top ten stocks shows a general decline, with North Huachuang down by 2.00% and Weir Shares (603501) down by 3.17% [8]

Group 1: Company Value Management - The company emphasizes value management through improving operational performance and effective communication with investors [2][3] - Measures include share buybacks, equity incentive plans, and maintaining good communication with the market to balance company value and market capitalization [3] Group 2: Accounts Receivable Management - The company has implemented a three-pronged approach to manage accounts receivable: pre-collection, during collection, and post-collection [3][12] - As of 2024, the company has achieved four consecutive years of positive operating cash flow [3] Group 3: Financial Performance - The company reported improved financial conditions in Q1 2025, with ongoing positive trends [4] - R&D expenses in 2024 amounted to 242 million CNY, representing 17.05% of revenue, indicating a commitment to maintaining technological leadership [12][13] Group 4: Product Applications and Collaborations - The company provides automotive communication products for various Geely models, including T-BOX and OBD, and has successfully integrated 5G products into Geely's high-end electric vehicles [5][9] - The company has shipped over 15 million electric vehicle digital number plates, indicating a strong presence in the digital management of electric bicycles [8] Group 5: Market Expansion and Challenges - The company has seen a 15.28% year-on-year increase in overseas revenue, reaching 219 million CNY in 2024 [9] - The company is actively exploring solutions to mitigate the impact of increased tariffs due to the US-China trade tensions, as its export business to the US is relatively small [10] Group 6: Governance and Shareholder Engagement - Independent directors are committed to protecting minority shareholders' interests through active communication and compliance with regulations [11] - The company has taken measures to improve performance after three consecutive years of losses, focusing on high-margin overseas markets and efficient cash flow management [11][12]